The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

IBM screens 14% below its $337 base-case target, backed by 15 buy ratings and an 80.5% prediction-market probability of a Q2 Software beat.

Arvind Krishna revealed IBM Z now runs 450 billion AI inferences daily, a Street-undermodeled edge that drove mainframe revenue up 51% in Q1.

IBM's Software grew 11.3% and Infrastructure margins nearly doubled to 15.8% year-over-year, representing structural edges Accenture cannot match. These advantages are further reinforced by IBM's 31-year dividend-raise streak.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks β€” and IBM didn't make the cut. Grab the names FREE today.

IBM (NYSE:IBM) ahead of its confirmed July 22 after-market report screens well for income-oriented portfolios: The model target puts base-case upside at 13.81%, prediction markets are already pricing in a beat and the dividend just got raised for the 31st year running. The setup carries high conviction on both valuation and catalyst timing.

On July 13, shares changed hands around $291.51 against a base-case target of $336.78 and a bull case of $355.64. Analyst coverage skews decisively positive at 15 Buy ratings against one Sell rating, and a beta of 0.68 means retirement accounts get the upside without the tech-sector whiplash.

The board pushed the quarterly dividend to $1.69, lifting the annualized forward payout to $6.76. That marks the 31st consecutive year of dividend increases, and management reaffirmed free cash flow growth of approximately $1 billion year-over-year in 2026. The check is written and the coverage is there.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks β€” and IBM didn't make the cut. Grab the names FREE today.

Polymarket contracts show an 80.5% probability that Q2 Software revenue clears $7.9 billion, with 68.5% odds of topping $8.05 billion. IBM has beaten EPS estimates five consecutive quarters, and Q1 delivered 9.46% revenue growth with IBM Z mainframe revenue up 51%. Arvind Krishna quantified the overlooked piece on the call: a fully populated Z system now runs "about 450 billion inferences a day", turning the mainframe from a cyclical hardware line into an AI inferencing engine the Street is still under-modeling.

Against Accenture (NYSE:ACN), the pure-play consulting peer, IBM's mix wins on every axis retirees care about. IBM Software grew 11.3% and Infrastructure 15.3% in Q1, while Infrastructure segment profit margin expanded to 15.8% from 8.6% year-on-year. Accenture carries no mainframe cycle, no equivalent recurring AI-inferencing hardware pull, and no 31-year dividend-raise streak. The head-to-head is a growth mix plus aristocrat-grade income against a single-lever consulting business.

Layer in the Confluent acquisition feeding live data into the GenAI pipeline, a P/E of 27 that leaves room and a more than 8% price appreciation in the past month and the setup writes itself.

The July 22 report is the near-term catalyst that will test the current setup.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks β€” and IBM didn't make the cut. Grab the names FREE today.

Contact editorial@247wallst.com for any questions or corrections.